EHAB vs. AVAH, AHCO, ADUS, BTSG, ALLO, ANL, AUNA, ZJYL, WGS, and LFMD
Should you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include Aveanna Healthcare (AVAH), AdaptHealth (AHCO), Addus HomeCare (ADUS), BrightSpring Health Services (BTSG), Allogene Therapeutics (ALLO), Adlai Nortye (ANL), Auna (AUNA), Jin Medical International (ZJYL), GeneDx (WGS), and LifeMD (LFMD). These companies are all part of the "medical" sector.
Enhabit (NYSE:EHAB) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, community ranking, profitability, analyst recommendations and risk.
Enhabit has a beta of 1.98, indicating that its stock price is 98% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 2.02, indicating that its stock price is 102% more volatile than the S&P 500.
In the previous week, Enhabit had 15 more articles in the media than Aveanna Healthcare. MarketBeat recorded 28 mentions for Enhabit and 13 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.75 beat Enhabit's score of 0.71 indicating that Aveanna Healthcare is being referred to more favorably in the news media.
Enhabit has higher earnings, but lower revenue than Aveanna Healthcare. Enhabit is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.
Enhabit presently has a consensus price target of $10.13, suggesting a potential upside of 17.12%. Aveanna Healthcare has a consensus price target of $1.80, suggesting a potential downside of 33.82%. Given Enhabit's stronger consensus rating and higher possible upside, equities research analysts clearly believe Enhabit is more favorable than Aveanna Healthcare.
Aveanna Healthcare has a net margin of -5.92% compared to Enhabit's net margin of -7.95%. Enhabit's return on equity of 1.43% beat Aveanna Healthcare's return on equity.
Aveanna Healthcare received 21 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 38.71% of users gave Aveanna Healthcare an outperform vote while only 12.00% of users gave Enhabit an outperform vote.
88.0% of Aveanna Healthcare shares are held by institutional investors. 1.9% of Enhabit shares are held by company insiders. Comparatively, 7.8% of Aveanna Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Summary
Aveanna Healthcare beats Enhabit on 11 of the 18 factors compared between the two stocks.
Get Enhabit News Delivered to You Automatically
Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EHAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
